Charles H Earnshaw

12PUBLICATIONS
35CO-AUTHORS
Artificial life and complex adaptive systemsSolid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 01, 2026
Real-world diagnostic performance of artificial intelligence in skin cancer screening.

|Jul 29, 2026
Multiple painful plaques and nodules.

|Oct 14, 2025
Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis.

Charles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang

|Aug 06, 2025
Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axis.

Charles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang

|Apr 20, 2022
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations.

Charlotte R Bell, Victoria S Pelly, Agrin Moeini

|May 13, 2021
Ultraviolet light-induced collagen degradation inhibits melanoma invasion.

Timothy Budden, Caroline Gaudy-Marqueste, Andrew Porter

Pageof 2

Frequent Collaborators

2 joint publications

Santiago Zelenay

2 joint publications

Eduardo Bonavita

2 joint publications

Maria A Koufaki

2 joint publications

Charlotte R Bell